Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)
Press Releases
Glenmark Pharmaceuticals Ltd  
February 14, 2025

Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)

MAHWAH, N.J., Feb. 14, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch1 of Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL). Glenmark's Latanoprost Ophthalmic Solution, 0.005%

avatar profile Olean Times Herald

Olean Times Herald


Local & Social